Inventor

SHUHUI CHEN

Inventor

CN

Overview

2021–2026

Patent span

Human necessities

Primary field (CPC A)

Patents· 153 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%

C07DHeterocyclic compounds30%

A61KPreparations for medical, dental or toiletry purposes24%

C07BGeneral methods of organic chemistry7%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%

C07KPeptides1%

Y02PClimate change mitigation technologies in the production or processing of goods1%

C07CAcyclic or carbocyclic compounds1%

C07HSugars1%

Y02ATechnologies for adaptation to climate change1%

PatentTitleYear

12,595,259Aminopyridine compound2026 12,590,082Fused tricyclic derivative and pharmaceutical application thereof2026 12,583,8462H-benzopyran derivatives as CRAC inhibitors2026 12,583,841Tetrahydropyrrolocyclic compound and application thereof2026 12,577,2535,6-dihydrothieno[3,4-h]quinazoline compound2026 12,577,246Indoline compound2026 12,570,653Pyrimidine ring compound2026 12,565,480Thiophene derivatives as xanthine oxidase inhibitors and application thereof2026 12,565,477Preparation method for chlorinated compound2026 12,565,4816,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RET2026 12,552,813Heterocyclic substituted pyrimidopyran compound and use thereof2026 12,552,7891H-pyrrolo[2,3-c]pyridine compounds and application thereof2026 12,552,812Pyridone multiple-membered ring derivatives and use thereof2026 12,552,787Quinazoline compound2026 12,545,648Benzopyrazole compound2026 12,539,335Tricyclic polypeptide conjugated drug and use thereof2026 12,534,477Compound having KHK inhibitory effect2026 12,522,616Thiazololactam compound as ERK inhibitor and use thereof2026 12,516,070Fused ring derivatives and use thereof in pharmacy2026 12,516,057Crystalline form of TLR8 agonist2026 12,516,049Sulfonylurea ring substituted monocyclic b-lactam antibiotics2026 12,509,440Fluorovinylbenzamide compound as PD-L1 immunomodulator2025 12,497,412Compound as highly selective ROS1 inhibitor and use thereof2025 12,492,215Pyrrolotriazine compounds acting as MNK inhibitor2025 12,492,169Aminopyridine compound and application thereof2025 12,486,266Crystalline form of JAK inhibitor and application thereof2025 12,479,794Acetophenone oxime compound and application thereof2025 12,479,823Compound for use in retinal diseases2025 12,479,800Phenylpropionamide compound and use thereof2025 12,479,839Crystalline form of ATR inhibitor and use thereof2025 12,473,258Crystal form of pyridinylphenyl compound and preparation method therefor2025 12,466,816Fused cyclic compound capable of degrading protein and use thereof2025 12,466,817Pyridine derivative and application thereof2025 12,459,918Isoquinolinone derivatives serving as rock protein kinase inhibitors and use thereof2025 12,458,647Macrocyclic derivative and use thereof2025 12,459,940Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK2025 12,448,378Fluoropyrrolopyridine compound and application thereof2025 12,435,101Isochroman compound2025 12,428,391Dimethylsulfoximine derivative2025 12,421,269SGLT2/DPP4 inhibitor and application thereof2025 12,421,236Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor2025 12,415,799Indazole-fused cyclic compound2025 12,410,155Salt form and crystal form of tetrahydrocyclohepta indazole compound2025 12,410,196Benzopyrimidine compounds and use thereof2025 12,398,138FGFR inhibitor compound in solid form and preparation method therefor2025 12,398,153Spiro compound serving as ERK inhibitor, and application thereof2025 12,378,241Pyridine derivative as FGFR and VEGFR dual inhibitors2025 12,378,253Pyrrolopyrimidine compound as BTK inhibitor and use thereof2025 12,378,277SGLTS/DPP4 inhibitor and application thereof2025 12,365,686Compound as porcupine inhibitor and use thereof2025 12,358,927IRAK4 inhibitor crystal and preparation method therefor2025 12,351,587Bicyclic compound as RIP-1 kinase inhibitor and application thereof2025 12,351,590Pyrrolopyrimidine compound and use thereof2025 12,338,263Antibacterial aminoglycoside derivatives2025 12,325,6955-(4-pyridyloxy)pyrazole compounds serving as TGF-bR1 kinase inhibitor2025 12,325,703Fused ring compound as FGFR and VEGFR dual inhibitor2025 12,319,692Anti-influenza virus pyrimidine derivatives2025 12,310,948Application of monocyclic b-lactam compound in pharmacy2025 12,312,347Azaindole derivative and use thereof as FGFR and C-Met inhibitor2025 12,297,197Pyrazolopyridine compound as RET inhibitor and application thereof2025 12,291,536Crystal form of Wee1 inhibitor compound and use thereof2025 12,258,367Glucoside derivative that acts as SGLT1 inhibitor and application thereof2025 12,240,849Nitrogen-containing spiro derivative as RET inhibitor2025 12,221,432Estrogen receptor antagonist2025 12,180,184Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof2024 12,162,880Pyrimidoheterocyclic compounds and application thereof2024 12,152,013Vinylpyridine carboxamide compound as PD-L1 immunomodulator2024 12,122,780Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor2024 12,116,367Ring-modified proline short peptide compound and use thereof2024 12,077,513Process route of compound of formula (IV), crystal form and preparation method therefor2024 12,071,435TLR8 agonist2024 12,054,482TLR8 agonist2024 12,030,897Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof2024 12,024,494Salt of LSD1 inhibitor and a polymorph thereof2024 12,018,027Macrocyclic derivatives acting as XIa factor inhibitor2024 12,012,404Pyrimidoheterocyclic compounds and application thereof2024 11,993,596Fused tri-cyclic compound as PDE3/PDE4 dual inhibitor2024 11,932,652Pyrrolidinyl urea derivatives and application thereof in TrkA-related diseases2024 11,932,617Compound for use in retinal diseases2024 11,919,896[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof2024 11,905,276Bicyclic compound that acts as CRBN protein regulator2024 11,891,3982,3-dihydro-1H-pyrrolizine-7-formamide derivative and application thereof2024 11,866,433Diarylthiohydantoin compound as androgen receptor antagonist2024 11,814,371Heterocyclic compound2023 11,760,751Benzo 2-azaspiro[4.4]nonane compound and use thereof2023 11,753,377Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound2023 11,739,090Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors2023 11,725,009Anti-influenza virus pyrimidine derivative2023 11,718,610Compounds containing benzosultam2023 11,702,400Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors2023 11,691,9743,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors2023 11,680,070Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof2023 11,680,061Crystal forms C and E of pyrazin-2(1H)-one compound and preparation method therefor2023 11,667,667Steroid derivative FXR agonist2023 11,655,248Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor2023 11,649,245Cyclopropylamine compound as LSD1 inhibitor and use thereof2023 11,639,355Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors2023 11,634,424Diazaindole derivative and use thereof as CHK1 inhibitor2023 11,623,923Uracil compound as c-MET/AXL inhibitor2023 11,613,545Macrocyclic compound serving as Wee1 inhibitor and applications thereof2023 11,603,366Crystalline form and B crystalline form of pyrazine-2(1H)-ketone compound and preparation method thereof2023 11,597,722Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor2023 11,572,372Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds2023 11,542,272Five-membered heteroaryl-fused imidazole compound and application thereof2023 11,535,613Crystal form and salt form of pyridoimidazole compound and preparation method therefor2022 11,535,609Pyrazine-2(1H)-ketone compound preparation method2022 11,530,196Pyrimidine compound acting on EGFR and ERBB22022 11,524,941Pyrazole compounds as LSD1 inhibitors and applications thereof2022 11,524,958Tricyclic compound as CRTH2 inhibitor2022 11,505,532SSAO inhibitor2022 11,464,780Pyrazolopyrimidine derivative and use thereof2022 11,466,036Borate of azetidine derivative2022 11,459,323Monocyclic b-lactam compound for treating bacterial infection2022 11,459,337Isothiazolo[5,4-D]pyrimidine compound as IRAK4 inhibitor2022 11,453,667Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor2022 11,440,903Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof2022 11,433,053LSD1 inhibitor and preparation method and application thereof2022 11,434,212Bicyclic compound as a caspase inhibitor2022 11,434,232ATR inhibitor and application thereof2022 11,427,581JAK inhibitor and use thereof2022 11,407,717Benzimidazole derivatives and use thereof as IDH1 inhibitors2022 11,396,493Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereof2022 11,390,625Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor2022 RE049128Hydroxyl purine compounds and applications thereof2022 11,384,065Heterocyclic compound as CSF-1R inhibitor and use thereof2022 11,377,444Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors2022 11,358,950SMAC mimetics used as IAP inhibitors and use thereof2022 11,352,331Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor2022 11,345,678Benzopyrazole compound used as RHO kinase inhibitor2022 11,339,147Lactam compound as FXR receptor agonist2022 11,332,465Diarylthiohydantoin compound as androgen receptor antagonist2022 11,319,330Tricyclic furan-substituted piperidinedione compound2022 11,319,305Pyrimidine sulfamide derivative and preparation method and medical application thereof2022 11,312,726Thienodiazepine derivatives and application thereof2022 11,312,715Fused ring derivative as A2022 11,299,475Prostacyclin receptor agonist2022 11,286,248Pyrazine-2(1H)-ketone compound acting as FGFR inhibitor2022 11,254,666Compound as GLS1 inhibitor2022 11,251,948Encryption and decryption method and system with continuous-variable quantum neural network2022 11,236,107Crystal of tricyclic compound2022 11,236,094Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors2022 11,236,112Crystal form and salt form of TGF-bRI inhibitor and preparation method therefor2022 11,230,544Substituted 1,3,4-thiadiazoles as GLS1 inhibitors2022 11,230,549Quinolino-pyrrolidin-2-one derivative and application thereof2022 11,198,686Crystal form and salt form of pyridone compound and preparation method therefor2021 11,192,886S1P1 agonist and application thereof2021 11,174,270Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method thereof2021 11,161,817Quinoline derivative and use thereof as tyrosine kinase inhibitor2021 11,155,523Biphenyl compound as CCR2/CCR5 receptor antagonist2021 11,155,559Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity2021 11,149,055Crystal form of lanosterol prodrug compound and application thereof2021 11,136,315CXCR2 antagonist2021 11,136,319Anti-influenza virus pyrimidine derivative2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2026Patents assigned to MEDSHINE DISCOVERY INC (40)· patent assignee history

2021–2025Patents assigned to GUANGDONG RAYNOVENT BIOTECH CO LTD (6)· patent assignee history

2021–2026Based in CN· patent location history

2022–2026Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (20)· patent assignee history

2022–2026Patents assigned to ZHUHAI UNITED LABORATORIES CO LTD (8)· patent assignee history

2022–2025Patents assigned to CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MEDSHINE DISCOVERY INC	40	2021–2026
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD	20	2022–2026
ZHUHAI UNITED LABORATORIES CO LTD	8	2022–2026
CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD	6	2022–2025
GUANGDONG RAYNOVENT BIOTECH CO LTD	6	2021–2025

Locations

Location	Patents	Span
CN	153	2021–2026